Skip to main content
. 2023 Sep 22;12(19):6124. doi: 10.3390/jcm12196124

Figure 1.

Figure 1

CAR-T cell therapy. The CAR-T cells are expanded before infusion into the patient’s bloodstream following lymphodepletion chemotherapy (LDC). Once in the body, the genetically modified chimeric antigen receptors (CARs) allow the T cells collected from the patient to recognize and attack cancer cells expressing specific antigens.